Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program
- PMID: 35568752
- DOI: 10.1007/s00535-022-01878-4
Effect of gastric cancer screening on long-term survival of gastric cancer patients: results of Korean national cancer screening program
Abstract
Background: Gastric cancer (GC) is the most common cancer type in Korea. Korean National Cancer Screening Program (KNCSP) offer either upper gastrointestinal series (UGIS) or upper endoscopy biennially for adults aged ≥ 40. This study aimed to investigate the effect of cancer screening program on the long-term survival among GC patients.
Methods: A nationwide population-based cohort was constructed based on three national databases. Overall, 46,701 GC patients diagnosed in 2008 and 2009 were included in our final analysis, and they were followed-up until the end of 2019. Survival curves were estimated using the Kaplan-Meier analysis with the log-rank test. Cox proportional-hazards regression analysis was used to report the hazard ratios (HRs) with 95% confidence intervals.
Results: A total of 18,614/46,701 (39.9%) patients died during the median follow-up time of 10.5 years. The survival rate was higher among screened patients (65.8%) than never-screened patients (49.1%). Screened patients had 53% (HR, 0.47; 95% CI 0.45-0.48) lower risk of death from GC. The HRs of GC-specific mortality was lower in upper endoscopy group (HR = 0.36; 95% CI = 0.34-0.37) compared with UGIS (HR = 0.69; 95% CI = 0.67-0.73). Screened patients within 2 years prior to cancer diagnosis had a 35% reduction in risk of GC death. The figure decline to approximately 19% among patients with interval time since last screening of > 3 years.
Conclusions: Our findings emphasized the positive effects of GC screening on long-term GC patient survival. Also, patients screened by upper endoscopy or within 2 years before diagnosis had the best survival outcomes.
Keywords: Endoscopy; Gastric cancer; Mass screening; Photofluorography; Survival.
© 2022. Japanese Society of Gastroenterology.
Similar articles
-
Risk of upper gastrointestinal cancer and death in persons with negative screening results: results from the National Cancer Screening Program in South Korea.Gastric Cancer. 2023 Jul;26(4):580-589. doi: 10.1007/s10120-023-01387-0. Epub 2023 Apr 5. Gastric Cancer. 2023. PMID: 37020074
-
Trends in the Performance of the Korean National Cancer Screening Program for Gastric Cancer from 2007 to 2016.Cancer Res Treat. 2022 Jul;54(3):842-849. doi: 10.4143/crt.2021.482. Epub 2021 Sep 30. Cancer Res Treat. 2022. PMID: 34607395 Free PMC article.
-
Who participates in the gastric cancer screening and on-time rescreening in the National Cancer Screening Program? A population-based study in Korea.Cancer Sci. 2011 Dec;102(12):2241-7. doi: 10.1111/j.1349-7006.2011.02090.x. Epub 2011 Sep 27. Cancer Sci. 2011. PMID: 21895871
-
Gastric cancer screening: a systematic review and meta-analysis.Scand J Gastroenterol. 2022 Oct;57(10):1178-1188. doi: 10.1080/00365521.2022.2068966. Epub 2022 May 9. Scand J Gastroenterol. 2022. PMID: 35531944
-
Is screening and surveillance for early detection of gastric cancer needed in Korean Americans?Korean J Intern Med. 2015 Nov;30(6):747-58. doi: 10.3904/kjim.2015.30.6.747. Epub 2015 Oct 30. Korean J Intern Med. 2015. PMID: 26552450 Free PMC article. Review.
Cited by
-
Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline).J Gastric Cancer. 2025 Jan;25(1):5-114. doi: 10.5230/jgc.2025.25.e11. J Gastric Cancer. 2025. PMID: 39822170 Free PMC article. Review.
-
Randomized controlled trial comparing the costs of gastric cancer screening systems between serological risk-based upper gastrointestinal endoscopy and the existing barium photofluorography: gastric cancer screening labeled by serum examination in place of aged gastric cancer organized screening systems (GALAPAGOS study).Gastric Cancer. 2024 Jan;27(1):36-48. doi: 10.1007/s10120-023-01449-3. Epub 2023 Nov 25. Gastric Cancer. 2024. PMID: 38006568 Clinical Trial.
-
Recommendations for gastric cancer prevention and control in the Americas.Lancet Reg Health Am. 2023 Oct 6;27:100608. doi: 10.1016/j.lana.2023.100608. eCollection 2023 Nov. Lancet Reg Health Am. 2023. PMID: 37840576 Free PMC article. No abstract available.
-
Socioeconomic inequality in organized and opportunistic screening for gastric cancer: results from the Korean National Cancer Screening Survey 2009-2022.Front Public Health. 2023 Oct 9;11:1256525. doi: 10.3389/fpubh.2023.1256525. eCollection 2023. Front Public Health. 2023. PMID: 37876718 Free PMC article.
-
Impact of the COVID-19 Pandemic on Gastric Cancer Screening in South Korea: Results From the Korean National Cancer Screening Survey (2017-2021).J Gastric Cancer. 2022 Oct;22(4):264-272. doi: 10.5230/jgc.2022.22.e36. J Gastric Cancer. 2022. PMID: 36316105 Free PMC article. Review.
References
-
- Ferlay J, Ervik M, Lam F et al. (2020) Global cancer observatory: cancer today. Lyon, France: international agency for research on cancer. Available from: https://gco.iarc.fr/today . Accessed 04 Jul 2021
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous